Annual total expenses:
$327.85M+$1.05M(+0.32%)Summary
- As of today (September 10, 2025), CPRX annual total expenses is $327.85 million, with the most recent change of +$1.05 million (+0.32%) on December 31, 2024.
- During the last 3 years, CPRX annual total expenses has risen by +$226.49 million (+223.47%).
- CPRX annual total expenses is now at all-time high.
Performance
CPRX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$94.45M+$9.77M(+11.54%)Summary
- As of today (September 10, 2025), CPRX quarterly total expenses is $94.45 million, with the most recent change of +$9.77 million (+11.54%) on June 30, 2025.
- Over the past year, CPRX quarterly total expenses has increased by +$12.54 million (+15.31%).
- CPRX quarterly total expenses is now -29.22% below its all-time high of $133.45 million, reached on September 30, 2023.
Performance
CPRX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CPRX Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.3% | +15.3% |
3 y3 years | +223.5% | +199.9% |
5 y5 years | +365.5% | +376.4% |
CPRX Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +223.5% | -29.2% | +199.9% |
5 y | 5-year | at high | +643.6% | -29.2% | +773.6% |
alltime | all time | at high | >+9999.0% | -29.2% | +773.6% |
CPRX Total expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $94.45M(+11.5%) |
Mar 2025 | - | $84.68M(-1.4%) |
Dec 2024 | $327.85M(+0.3%) | $85.88M(+1.3%) |
Sep 2024 | - | $84.81M(+3.5%) |
Jun 2024 | - | $81.92M(+8.9%) |
Mar 2024 | - | $75.23M(-0.6%) |
Dec 2023 | $326.79M(+149.2%) | $75.72M(-43.3%) |
Sep 2023 | - | $133.45M(+115.9%) |
Jun 2023 | - | $61.82M(+10.8%) |
Mar 2023 | - | $55.80M(+58.1%) |
Dec 2022 | $131.12M(+29.4%) | $35.29M(+2.3%) |
Sep 2022 | - | $34.50M(+9.5%) |
Jun 2022 | - | $31.49M(+5.5%) |
Mar 2022 | - | $29.85M(+2.9%) |
Dec 2021 | $101.35M(+129.9%) | $29.00M(+13.2%) |
Sep 2021 | - | $25.63M(+6.0%) |
Jun 2021 | - | $24.18M(+7.3%) |
Mar 2021 | - | $22.54M(+15.1%) |
Dec 2020 | $44.09M(-37.4%) | $19.58M(-239.6%) |
Sep 2020 | - | -$14.02M(-170.7%) |
Jun 2020 | - | $19.82M(+6.0%) |
Mar 2020 | - | $18.71M(-15.7%) |
Dec 2019 | $70.43M(+104.1%) | $22.19M(+28.5%) |
Sep 2019 | - | $17.27M(-3.4%) |
Jun 2019 | - | $17.88M(+36.5%) |
Mar 2019 | - | $13.09M(-12.7%) |
Dec 2018 | $34.50M(+87.4%) | $15.00M(+91.3%) |
Sep 2018 | - | $7.84M(+31.4%) |
Jun 2018 | - | $5.97M(+4.7%) |
Mar 2018 | - | $5.70M(+5.8%) |
Dec 2017 | $18.41M(+1.9%) | $5.39M(+29.0%) |
Sep 2017 | - | $4.18M(+7.7%) |
Jun 2017 | - | $3.88M(-21.9%) |
Mar 2017 | - | $4.97M(+19.3%) |
Dec 2016 | $18.07M(-10.7%) | $4.16M(+5.3%) |
Sep 2016 | - | $3.95M(-13.5%) |
Jun 2016 | - | $4.57M(-15.2%) |
Mar 2016 | - | $5.39M(-7.4%) |
Dec 2015 | $20.23M | $5.82M(+30.7%) |
Sep 2015 | - | $4.45M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $4.56M(-15.7%) |
Mar 2015 | - | $5.41M(+55.0%) |
Dec 2014 | $15.51M(+27.6%) | $3.49M(-30.3%) |
Sep 2014 | - | $5.01M(+56.7%) |
Jun 2014 | - | $3.20M(-16.1%) |
Mar 2014 | - | $3.81M(+181.3%) |
Dec 2013 | $12.15M(+198.2%) | $1.35M(-77.1%) |
Sep 2013 | - | $5.91M(+88.1%) |
Jun 2013 | - | $3.14M(+80.2%) |
Mar 2013 | - | $1.74M(+2177.2%) |
Dec 2012 | $4.08M(-36.2%) | $76.60K(-97.1%) |
Sep 2012 | - | $2.62M(+806.8%) |
Jun 2012 | - | $289.10K(-73.5%) |
Mar 2012 | - | $1.09M(-53.7%) |
Dec 2011 | $6.39M(+59.5%) | $2.35M(+108.5%) |
Sep 2011 | - | $1.13M(-19.1%) |
Jun 2011 | - | $1.39M(-8.1%) |
Mar 2011 | - | $1.52M(+108.2%) |
Dec 2010 | $4.01M(-44.7%) | $728.80K(-19.4%) |
Sep 2010 | - | $904.00K(-32.0%) |
Jun 2010 | - | $1.33M(+27.1%) |
Mar 2010 | - | $1.04M(-10.1%) |
Dec 2009 | $7.24M(-31.5%) | $1.16M(-9.7%) |
Sep 2009 | - | $1.29M(-27.0%) |
Jun 2009 | - | $1.76M(-41.9%) |
Mar 2009 | - | $3.03M(-19.1%) |
Dec 2008 | $10.56M(+155.2%) | $3.75M(+31.3%) |
Sep 2008 | - | $2.86M(+20.1%) |
Jun 2008 | - | $2.38M(+50.1%) |
Mar 2008 | - | $1.58M(+67.6%) |
Dec 2007 | $4.14M(+51.7%) | $944.90K(+28.7%) |
Sep 2007 | - | $734.30K(-39.2%) |
Jun 2007 | - | $1.21M(-3.5%) |
Mar 2007 | - | $1.25M(+68.9%) |
Dec 2006 | $2.73M(+51.2%) | $741.20K(-43.9%) |
Sep 2006 | - | $1.32M(+270.1%) |
Jun 2006 | - | $357.00K |
Dec 2005 | $1.81M(+234.5%) | - |
Dec 2004 | $539.80K(+25.9%) | - |
Dec 2003 | $428.60K(+67.5%) | - |
Dec 2002 | $255.90K | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual total expenses?
- What is the all time high annual total expenses for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of CPRX is $327.85M
What is the all time high annual total expenses for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual total expenses is $327.85M
What is Catalyst Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, CPRX annual total expenses has changed by +$1.05M (+0.32%)
What is Catalyst Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of CPRX is $94.45M
What is the all time high quarterly total expenses for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly total expenses is $133.45M
What is Catalyst Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, CPRX quarterly total expenses has changed by +$12.54M (+15.31%)